FDA Inspection 1255961 — UC San Diego Health Clinical Lab - Hillcrest
The FDA completed an inspection of UC San Diego Health Clinical Lab - Hillcrest on October 29, 2024 in San Diego, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 29, 2024
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- San Diego, CA (United States)